April 2, 2019
Encore Dermatology Inc. Acquires SERNIVO®, TRIANEX® and PROMISEB®
MALVERN, Pa.–(BUSINESS WIRE)–Encore Dermatology Inc. announced today that it has acquired rights for SERNIVO® (betamethasone dipropionate) Spray, 0.05%, as well…